Clinical Trials Browser

Phase 2/3 × Has results × Breast Neoplasms × Clear all

NCT04191499 2026-03-17

INAVO120

Phase 2/3 Active not recruiting

325 enrolled 14 charts 1 FDA

Breast Neoplasms

NCT04862585 2025-08-20

Safely Stopping Pre-medications in Patients With Breast Cancer Who Are Receiving Paclitaxel

Phase 2/3 Completed

130 enrolled 8 charts

Breast Carcinoma In Situ, Breast Neoplasms

NCT02068092 2023-10-10

Olive Oil for High Risk Breast Cancer Prevention in Women

Phase 2/3 Completed

51 enrolled 6 charts

Breast Neoplasms

NCT03716050 2020-05-21

The Effect of Nitroglycerin Ointment, Fluorescent Angiography, and Incisional Negative Pressure Wound Therapy on Mastectomy Skin Flap Perfusion-Related Problems

Phase 2/3 Terminated

17 enrolled 10 charts

Breast Neoplasms

NCT00418028 2019-02-22

Standard Versus Continuous Capecitabine in Advanced Breast Cancer

Phase 2/3 Completed

195 enrolled 15 charts

Breast Neoplasms

NCT01881230 2019-02-21

tnAcity

Phase 2/3 Completed

191 enrolled 22 charts

Breast Neoplasms, Triple Negative Breast Neoplasms

NCT00169104 2018-07-20

Effects of Granulocyte Colony-stimulating Factor (G-CSF), Trastuzumab, and Vinorelbine on Immune Cell Function

Phase 2/3 Terminated

23 enrolled 10 charts

Breast Neoplasms

NCT01572727 2017-03-09

BELLE-4

Phase 2/3 Completed

416 enrolled 11 charts

Breast Neoplasms, Neoplasm Metastasis, Hereditary Sensory and Autonomic Neuropathies

NCT01355523 2014-05-06

MELODY

Phase 2/3 Terminated

54 enrolled 27 charts

Anxiety Disorders, Breast Neoplasms, Depression, Parasomnias